ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,196 | -47,528 | -17,425 | -7,584 | 2,791 |
| Depreciation Amortization | 168 | 137 | 43 | 90 | 118 |
| Accounts receivable | N/A | N/A | -215 | 10,496 | -10,511 |
| Other Working Capital | 2,777 | -1,579 | 639 | 7,609 | -8,983 |
| Other Operating Activity | 3,154 | 30,538 | 1,422 | -9,870 | 11,587 |
| Operating Cash Flow | $-40,098 | $-18,431 | $-15,536 | $740 | $-4,997 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 3,026 | 11,980 | -11,210 | 4,995 |
| PPE Investments | -60 | -166 | -651 | -29 | -39 |
| Investing Cash Flow | $-60 | $2,861 | $11,329 | $-11,239 | $4,956 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48,455 | 11,353 | 380 | 18,495 | 7,384 |
| Other Financing Activity | 0 | 22,315 | -60 | 0 | 0 |
| Financing Cash Flow | $48,455 | $33,668 | $319 | $18,495 | $7,384 |
| Beginning Cash Position | 29,859 | 11,761 | 15,649 | 7,654 | 311 |
| End Cash Position | 38,155 | 29,859 | 11,761 | 15,649 | 7,654 |
| Net Cash Flow | $8,297 | $18,098 | $-3,888 | $7,995 | $7,343 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,098 | -18,431 | -15,536 | 740 | -4,997 |
| Capital Expenditure | -63 | -166 | -651 | -29 | -39 |
| Free Cash Flow | -40,161 | -18,597 | -16,187 | 711 | -5,036 |